We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ICCC market cap is 39.06M. The company's latest EPS is USD -0.7451 and P/E is -6.75.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.8M | 3.91M | 3.45M | 3.53M | 5.4M |
| Operating Income | -838k | -1.63M | -2.26M | -1.3M | -1.18M |
| Net Income | -878k | -1.67M | -2.32M | -1.38M | -940k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 13.72M | 15.34M | 19.24M | 18.57M | 17.47M |
| Operating Income | -954k | -1.38M | 257k | -2.3M | -5.75M |
| Net Income | -1.3M | -1.02M | -78k | -2.49M | -5.78M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.4M | 44.86M | 43.12M | 44.01M | 44.55M |
| Total Liabilities | 14.42M | 14.48M | 14.96M | 17.15M | 18.53M |
| Total Equity | 31.98M | 30.38M | 28.16M | 26.86M | 26.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 38.69M | 40.35M | 44.47M | 44.86M | 43.81M |
| Total Liabilities | 9.7M | 12.08M | 11.89M | 14.48M | 18.82M |
| Total Equity | 28.99M | 28.27M | 32.58M | 30.38M | 24.99M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -246k | -1.54M | -2.76M | -3.44M | -3.95M |
| Investing | -2.47M | -3.96M | -682k | -1.39M | -1.92M |
| Financing | 1.36M | 1.12M | 748k | 496k | 2.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 234k | 1.32M | 954k | -1.54M | -4.67M |
| Investing | -3.4M | -2.57M | -1.6M | -3.96M | -1.89M |
| Financing | 6.94M | 1.91M | 3.88M | 1.12M | 1.75M |
| Market Cap | 39.06M |
| Price to Earnings Ratio | -6.75 |
| Price to Sales Ratio | 2.23 |
| Price to Cash Ratio | 39.83 |
| Price to Book Ratio | 1.56 |
| Dividend Yield | - |
| Shares Outstanding | 7.75M |
| Average Volume (1 week) | 3.02k |
| Average Volume (1 Month) | 8.37k |
| 52 Week Change | 2.23% |
| 52 Week High | 6.05 |
| 52 Week Low | 4.34 |
| Spread (Intraday) | 0.48 (9.21%) |
| Company Name | ImmuCell Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.immucell.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
